<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367444"><TermName>epothilone D</TermName><TermPronunciation>(eh-POTH-ih-lone ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is a type of mitotic inhibitor and epothilone. Also called KOS-862.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711699" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epothilone D&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711698" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epotilona D&quot;" language="es" id="_4"/><SpanishTermName>epotilona D</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor mitótico y de epotilona. También se llama KOS-862.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2007-03-19</DateLastModified></GlossaryTerm>
